版本:
中国

更多 瑞士市场报道 新闻

FACTBOX-Drugmakers rush to develop COVID-19 treatments

Drugmakers around the world are rushing to develop treatments for COVID-19, the respiratory disease caused by the novel coronavirus that has killed hundreds of thousands. Several companies are developing antibody treatments, similar to Regeneron Pharmaceutical Inc's treatment given to U.S. President Donald Trump for his COVID-19 infection. On Thursday, the U.S. Food and Drug Administration approved Gilead Sciences Inc's antiviral drug remdesivir for

FOREX-Dollar eases off 7-week low as COVID-19 aid bill in doubt

The dollar index ticked higher on Thursday, easing off a seven-week low as hopes for a coronavirus aid package ahead of the U.S. elections faded and COVID-19 cases surged around the world, giving a slight bid to safe-haven assets like the greenback. Investors were also digesting new U.S. jobless claims data that showed a bigger-than-expected drop, but remained at extremely high levels amid fading fiscal stimulus and a resurgent coronavirus

FOREX-Dollar edges off of 7-week lows amid stimulus uncertainty

The dollar index edged higher on Thursday, backing off of a seven-week low as hopes for a coronavirus relief package ahead of the Nov. 3 U.S. elections faded and COVID-19 cases surged around the world, boosting demand for safe-haven assets like the greenback. Investors were also digesting new U.S. jobless claims data that showed a bigger-than-expected drop, but remained at extremely high levels, indicating a slowdown in the labor market an